JP2022543038A5 - - Google Patents

Info

Publication number
JP2022543038A5
JP2022543038A5 JP2022506401A JP2022506401A JP2022543038A5 JP 2022543038 A5 JP2022543038 A5 JP 2022543038A5 JP 2022506401 A JP2022506401 A JP 2022506401A JP 2022506401 A JP2022506401 A JP 2022506401A JP 2022543038 A5 JP2022543038 A5 JP 2022543038A5
Authority
JP
Japan
Prior art keywords
polymerosomes
group
antigen
poly
pharmaceutical product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506401A
Other languages
English (en)
Japanese (ja)
Other versions
JP7676030B2 (ja
JP2022543038A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/071809 external-priority patent/WO2021019102A2/en
Publication of JP2022543038A publication Critical patent/JP2022543038A/ja
Publication of JP2022543038A5 publication Critical patent/JP2022543038A5/ja
Application granted granted Critical
Publication of JP7676030B2 publication Critical patent/JP7676030B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506401A 2019-08-01 2020-08-03 関連づけられた抗原を有するポリマーソームの集団を、関連づけられたアジュバントを有するポリマーソームの集団と一緒に投与することによって、免疫応答を誘発する方法、およびそれら2つのポリマーソーム集団を含む組成物 Active JP7676030B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19189549.9 2019-08-01
EP19189549 2019-08-01
EP20171327.8 2020-04-24
EP20171327 2020-04-24
PCT/EP2020/071809 WO2021019102A2 (en) 2019-08-01 2020-08-03 A method of eliciting an immune response by administering a population of polymersomes having an associated antigen together with a population of polymersomes having an associated adjuvant as well as compositions comprising the two populations of polymersomes

Publications (3)

Publication Number Publication Date
JP2022543038A JP2022543038A (ja) 2022-10-07
JP2022543038A5 true JP2022543038A5 (cg-RX-API-DMAC10.html) 2024-02-20
JP7676030B2 JP7676030B2 (ja) 2025-05-14

Family

ID=72148072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506401A Active JP7676030B2 (ja) 2019-08-01 2020-08-03 関連づけられた抗原を有するポリマーソームの集団を、関連づけられたアジュバントを有するポリマーソームの集団と一緒に投与することによって、免疫応答を誘発する方法、およびそれら2つのポリマーソーム集団を含む組成物

Country Status (9)

Country Link
US (1) US20220273792A1 (cg-RX-API-DMAC10.html)
EP (1) EP4007597A2 (cg-RX-API-DMAC10.html)
JP (1) JP7676030B2 (cg-RX-API-DMAC10.html)
CN (1) CN114502191B (cg-RX-API-DMAC10.html)
AU (1) AU2020322107A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022001185A2 (cg-RX-API-DMAC10.html)
CA (1) CA3143533A1 (cg-RX-API-DMAC10.html)
PH (1) PH12022550112A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021019102A2 (cg-RX-API-DMAC10.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111450060A (zh) * 2012-11-19 2020-07-28 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
US20180128545A1 (en) 2016-11-08 2018-05-10 Berry Metal Company Modular furnace cooling wall
CA3131096A1 (en) 2019-04-05 2020-10-08 Chi-Huey Wong Sialidase-resistant saccharide and method of making and using the same
KR102657261B1 (ko) * 2020-04-03 2024-04-15 조선대학교산학협력단 Covid-19 진단을 위한 재조합 코로나-19 바이러스 스파이크 단백질의 생산 및 이의 용도
WO2021214339A2 (en) * 2020-04-24 2021-10-28 Acm Biolabs Pte Ltd Vaccine against human-pathogenic coronaviruses
CA3182526A1 (en) 2020-05-08 2021-11-11 Academia Sinica Chimeric influenza vaccines
JP7895943B2 (ja) * 2020-11-12 2026-07-28 ティースキャン セラピューティクス インコーポレイテッド Sars-cov-2免疫優性ペプチドの構築物及びその使用
EP4259197A1 (en) * 2020-12-11 2023-10-18 ACM Biolabs Pte Ltd Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant
CA3204785A1 (en) * 2021-02-02 2022-08-11 Madhavan Nallani Sole use of polymersome associated adjuvant for stimulating an immune response
CN115427432A (zh) * 2021-02-10 2022-12-02 斯微(上海)生物科技股份有限公司 一种治疗或者预防冠状病毒病突变株的疫苗试剂
IL305447A (en) * 2021-02-25 2023-10-01 Migvax Ltd Preparations for oral administration and their use in vaccination
US20240181041A1 (en) * 2021-03-16 2024-06-06 The Wistar Institute Adenovirus SARS-CoV-2 Vaccine
US20220323569A1 (en) * 2021-03-30 2022-10-13 Qiang Chen Plant-produced vlps and ric vaccines
WO2022212505A1 (en) * 2021-03-30 2022-10-06 Arizona Board Of Regents On Behalf Of Arizona State University Optimal production of sars-cov-2 virus-like particles (vlps) produced in mammalian cells
KR20230124888A (ko) * 2021-04-12 2023-08-28 아카데미아 시니카 광범위한 범위의 코로나바이러스 변이체에 대한 메신저 rna 백신
WO2022221837A2 (en) * 2021-04-12 2022-10-20 Academia Sinica Improved coronavirus vaccine
CN115337404A (zh) * 2021-05-12 2022-11-15 中国医学科学院基础医学研究所 细胞微颗粒在治疗呼吸道病毒性肺炎上的应用
WO2022251101A2 (en) * 2021-05-24 2022-12-01 nference, inc. Compositions and methods related to surge-associated sars-cov-2 mutants
WO2023004415A2 (en) * 2021-07-22 2023-01-26 University Of Miami Sars-cov-2 vaccine using bacterial spores expressing antigenic fragments
CN113633764B (zh) * 2021-09-02 2024-05-14 中国食品药品检定研究院 一种含佐剂的新冠dna疫苗
IT202100023816A1 (it) * 2021-09-16 2023-03-16 Takis S R L Anticorpo contro SARS-CoV-2 e suoi usi in campo medico.
TW202334429A (zh) 2021-10-01 2023-09-01 中央研究院 Sars-cov-2棘蛋白特異性抗體及其用途
WO2023060220A1 (en) * 2021-10-07 2023-04-13 BioVaxys Inc. Methods of immunization against coronavirus
CN114470186B (zh) * 2022-02-17 2023-10-20 唐颐控股(深圳)有限公司 一种可吸入式纳米新冠疫苗的制备方法
CA3268566A1 (en) 2023-04-08 2024-10-17 Rock Biomedical Inc. METHODS AND COMPOSITIONS FOR TARGETED DISTRIBUTION BY POLYMERSOMES
NZ825394A (en) 2023-04-08 2026-03-27 Rock Biomedical Inc Methods and compositions for dendritic cell targeting nano-delivery
CN121175414A (zh) 2023-05-17 2025-12-19 磐石医药生技股份有限公司 Mgat1缺乏细胞及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354934A (en) 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
AU760795B2 (en) * 1998-05-14 2003-05-22 Coley Pharmaceutical Gmbh Methods for regulating hematopoiesis using CpG-oligonucleotides
US6835394B1 (en) * 1999-12-14 2004-12-28 The Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
US20080181939A1 (en) * 1999-12-14 2008-07-31 Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
WO2009127537A1 (en) 2008-04-17 2009-10-22 GÜNZBURG, Walter Post release modification of viral envelopes
US8323696B2 (en) 2008-08-29 2012-12-04 Ecole Polytechnique Federale De Lausanne Nanoparticles for immunotherapy
US10364350B2 (en) 2009-04-20 2019-07-30 Agency For Science, Technology And Research Vesicular system and uses thereof
SG184127A1 (en) * 2010-03-19 2012-10-30 Massachusetts Inst Technology Lipid vesicle compositions and methods of use
WO2012018306A1 (en) 2010-08-05 2012-02-09 Agency For Science, Technology And Research A multicompartmentalized vesicular structure and a method for forming the same
CA3170184A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
US20150233800A1 (en) 2012-10-11 2015-08-20 Vin-De-Bona Trading Company Pte Ltd Method of painting microvesicles
CN111450060A (zh) * 2012-11-19 2020-07-28 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
EP2898894A1 (en) 2014-01-27 2015-07-29 LTS LOHMANN Therapie-Systeme AG Nano-in-micro particles for intradermal delivery
WO2016055611A1 (en) * 2014-10-09 2016-04-14 Universität Basel Self-assembled nanostructures and methods of use thereof
WO2016154432A1 (en) 2015-03-24 2016-09-29 VaxLiant, LLC Adjuvant compositions and related methods
JP7542257B2 (ja) * 2018-01-25 2024-08-30 エイシーエム バイオラブズ プライベート リミテッド 可溶化された封入抗原を含むポリマーソーム、ならびにその作製および使用方法
CN108969771B (zh) * 2018-08-07 2021-06-29 中国医学科学院生物医学工程研究所 甘露糖修饰的共载抗原和双免疫激动剂磷脂杂化聚合物囊泡及其制备方法与应用

Similar Documents

Publication Publication Date Title
US10973909B1 (en) Coronavirus vaccine
Li et al. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra-and paracellular pathways
JP2025107179A (ja) 治療に好適なrna製剤
Rattanakiat et al. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity
CN105473158B (zh) 呼吸道合胞病毒(rsv)疫苗
CN115867654A (zh) Rna构建体及其用途
Zhang et al. A comparative study of the antigen‐specific immune response induced by co‐delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles
Neshat et al. Gene delivery for immunoengineering
KR20220150342A (ko) 2019-ncov 서브유닛 백신 및 마이크로니들 어레이 전달 시스템
JP2021512142A5 (cg-RX-API-DMAC10.html)
Gupta et al. A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases
JP2023532290A5 (cg-RX-API-DMAC10.html)
ES2575395T3 (es) Composiciones para la transfección de células
Simón-Vázquez et al. Polymeric nanostructure vaccines: applications and challenges
Kabiri et al. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles
Todoroff et al. Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery
TW201026323A (en) Immunostimulatory oligonucleotides
JP2023549017A5 (cg-RX-API-DMAC10.html)
JP2009524584A (ja) ポリマー−生物製剤送達組成物を構築するための方法
CN113476598A (zh) 一种新型冠状病毒亚蛋白纳米疫苗及其制备方法和应用
JP2025500880A5 (cg-RX-API-DMAC10.html)
Brubaker et al. A cationic micelle complex improves CD8+ T cell responses in vaccination against unmodified protein antigen
Sinha et al. A user’s guide to designing efficient and safe mucosal vaccines: Challenges & potentials
JP2016517402A (ja) 自己組織化合成タンパク質(Self−AssemblingSyntheticProteins)
JP2024500360A5 (cg-RX-API-DMAC10.html)